Lyell Immunopharma, Inc. (LYEL) reported Q3 Revenue

Lyell Immunopharma, Inc. (NASDAQ: LYEL) reported Q3 Revenue for the quarter came in at $34 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Lyell Immunopharma, Inc. (LYEL) click here.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
• Gamma Resources raises private placement ceiling to $1.75M